Germany-based medical technology company MagForce has installed a NanoActivator at the University Hospital Munster. This NanoActivator has been installed at the University Hospital Munster as part of the preparations for the new ...
Tags: Glioblastoma study, NanoActivator, NanoTherm therapy, therapy
MagForce has obtained German Federal Institute for Drugs and Medical Devices' (BfArM) approval for the start of a post-marketing clinical study in recurrent glioblastoma patients. The controlled, open-label and randomized study will ...
Nanomedicine company MagForce has commenced a research project with the University of Bremen, Center for Environmental Research and Sustainable Technology, for the development of magnetic iron oxide particles. The collaboration, which ...
Medical technology company MagForce is planning to raise approximately€33.5m as part of its restructuring plan to safeguard its long-term existence. Under the restructuring plan approved the company's Supervisory Board,MagForce's ...
US medical center, Mayo Clinic, has signed a pre-clinical research agreement with MagForce. Under the agreement, Mayo Clinic will begin a research program to investigate the preclinical efficacy of the MagForce's NanoTherm therapy in ...
Tek Grup has entered into an agreement to distribute MagForce's NanoTherm therapy in Turkey, Albania, Iraq and Azerbaijan. The NanoTherm therapy is designed for the local treatment of solid tumors. As per the agreement, Tek Grup ...
Tags: Tek Grup, NanoTherm therapy, medical service, solid tumor